TL;DR: Crohn's disease is an inflammatory bowel disease (IBD) that must be declared on UK travel insurance applications. Insurers assess whether the condition is in remission, the type and frequency of medication, and any recent hospitalisations or flare-ups. Specialist insurers are available for those declined by mainstream providers. Full declaration is legally required and non-disclosure risks voiding any claim.
KEY FACTS
|
How UK Insurers Assess Crohn's Disease for Travel Insurance
Crohn's disease presents a complex underwriting challenge for travel insurers because of its relapsing and remitting nature. Unlike conditions with a static risk profile, Crohn's can be in full remission one month and in acute flare requiring hospitalisation the next. Insurers use medical screening questionnaires to categorise risk at the point of application, and the questions typically focus on the following: whether the condition is currently in remission, the date of the last flare-up or hospitalisation, the current medication regimen including whether biologics such as adalimumab or infliximab are prescribed, any recent change in treatment, and whether any surgery such as bowel resection has been performed and when. Crohn's in sustained remission - generally defined as no significant symptoms and no medication changes for 12 months or more - is typically assessed more favourably than active or recently active disease. However, the nature of IBD means that even in remission, the risk of a flare during travel is a factor that some mainstream insurers are not willing to accept. This creates a segmentation in the market: mainstream providers may offer cover with a Crohn's exclusion for related claims, while specialist medical travel insurers may be willing to include the condition at a premium loading after detailed assessment.
Medication, Biologics and Travelling Abroad with Crohn's
One practical dimension of travelling with Crohn's disease that intersects with insurance is the management of medication abroad. Many people with Crohn's are prescribed immunomodulators such as azathioprine or biologics administered by injection. Carrying these across international borders requires specific documentation, including a GP or consultant letter confirming the prescription and diagnosis, and in some cases advance notification to the destination country's health or customs authority. The UK Government's foreign travel advice pages at gov.uk/foreign-travel-advice carry country-specific information on medication entry requirements. Biologics that require refrigeration pose a logistical challenge on long-haul flights; NHS patient guidance recommends carrying a medical cooling wallet and confirming with the airline in advance that the medication can be stored appropriately. From an insurance perspective, the travel policy should cover the cost of emergency medical treatment if Crohn's flares abroad, including hospital admission and any required infusion therapy. Policies that exclude Crohn's-related claims will not cover these costs, leaving the traveller exposed to potentially very significant bills in countries without reciprocal healthcare arrangements. For EU and EEA destinations, a GHIC provides some protection by giving access to state hospital care, but state facilities may not always have the specific biologics prescribed, and the GHIC does not cover repatriation or private care.
Finding Specialist Travel Insurance for Crohn's Disease
Where mainstream insurers exclude Crohn's disease from their cover or decline to quote at all, specialist medical travel insurance providers offer an alternative route to cover. The MoneyHelper travel insurance directory at moneyhelper.org.uk lists providers specialising in pre-existing medical conditions, and BIBA's find-a-broker service connects applicants with experienced medical insurance brokers. Specialist providers conduct more detailed underwriting, often involving longer questionnaires that capture information about disease activity scores, specific medication, consultant follow-up frequency, and surgical history. This additional information allows them to price risk more accurately and in many cases to offer cover that includes Crohn's-related emergency claims rather than excluding them. Premium loadings vary considerably based on the stability of the condition, destination, and trip duration. Travellers should compare at least two specialist quotes alongside any mainstream quotes received, noting carefully what each policy includes and excludes for Crohn's specifically. Travellers with Crohn's alongside other declared conditions - such as anaemia, joint problems associated with IBD, or liver complications - should ensure all are declared, as undisclosed associated conditions carry the same non-disclosure risk as the primary diagnosis.
What a Travel Insurance Claim Involving Crohn's Might Look Like
Understanding what a claim scenario looks like in practice helps illustrate why adequate cover matters for Crohn's sufferers. A traveller in Florida who suffers a severe Crohn's flare requiring emergency admission to a US hospital faces average costs that can run to tens of thousands of pounds for inpatient gastrointestinal care. The US has no reciprocal public healthcare arrangement with the UK and is one of the most expensive destinations globally for medical treatment. Without a policy that covers Crohn's-related emergencies, the full cost falls to the traveller. For this reason, travellers with Crohn's visiting the USA, Canada, Australia, or other destinations without reciprocal state healthcare arrangements are particularly exposed when relying on policies that exclude IBD. In contrast, EU and EEA destinations offer state healthcare access via GHIC, though even there the GHIC does not cover repatriation if a traveller is too ill to use commercial flights and requires an air ambulance. Policies with adequate medical emergency limits - typically a minimum of £2 million for European travel and £5 million or more for long-haul, as referenced in MoneyHelper guidance - combined with cover that includes Crohn's disease provide the most comprehensive protection.
Renewal, Policy Reviews and Keeping Declarations Updated
Travel insurance for Crohn's disease is not a one-time exercise. Annual policies require renewal, and the medical declaration must reflect the current state of the condition at the point of each renewal. If Crohn's has been in remission since the last policy was taken out, this may improve the insurer's assessment. Conversely, if the condition has become more active, medication has changed, or surgery has occurred, this must be declared at renewal. The Consumer Insurance (Disclosure and Representations) Act 2012 applies with equal force at renewal as at inception. Travellers on long-term multi-trip policies should also be aware that a significant change in health mid-policy may require them to notify the insurer, particularly if the policy contains a clause requiring ongoing notification of material changes. Reading the policy terms on mid-term change of circumstances is advisable at purchase, not at claim time. If Crohn's enters or exits remission between policy inception and a planned trip, contacting the insurer to confirm the impact on cover is the safest course of action.
| Editorial Disclaimer: Kaeltripton.com is an independent editorial publisher and is not authorised or regulated by the Financial Conduct Authority. Content is for informational purposes only and does not constitute financial, investment, tax, legal or regulatory advice. Always verify rates and product details with the relevant provider, the FCA register, HMRC or the Bank of England before any financial decision. |
Frequently Asked Questions
Do I need to declare Crohn's disease even if it has been in remission for years?
Yes. Crohn's disease is a lifelong condition that will almost always fall within the look-back period defined in any travel insurance policy's pre-existing conditions clause. Even prolonged remission does not remove the obligation to declare. The medical screening process will determine how the condition is assessed and priced, but declaration is mandatory under the Consumer Insurance (Disclosure and Representations) Act 2012.
Will travel insurance cover a Crohn's flare abroad?
Only if the condition was declared, accepted, and included in the policy. If Crohn's was declared but excluded from cover, or if it was not declared at all, costs arising from a flare abroad will not be covered. Policies that include Crohn's after full declaration should cover emergency hospital admission, treatment, and in some cases repatriation if the traveller cannot return using scheduled transport.
Can I travel to the USA with Crohn's and get insurance?
Specialist medical travel insurance providers can often offer cover for US travel including Crohn's disease, though premiums for long-haul destinations with no reciprocal healthcare agreement are typically higher than for European travel. Given the potentially very high cost of emergency medical care in the USA, ensuring adequate cover limits - typically £5 million or more - is particularly important for US-bound travellers with IBD.
What documents should I carry when travelling with Crohn's disease?
Travellers with Crohn's should carry a GP or consultant letter confirming the diagnosis and current medication, a copy of all prescriptions, sufficient medication for the trip plus contingency, and their insurance policy documents including the emergency medical assistance contact number. Those on biologic medications should confirm in advance with the airline and destination authority whether any documentation or pre-notification is required for carrying injectable medication or refrigerated drugs.
Where can I find specialist travel insurance for Crohn's disease?
The MoneyHelper travel insurance directory at moneyhelper.org.uk provides a list of specialist insurers covering pre-existing medical conditions including IBD. The British Insurance Brokers Association (BIBA) find-a-broker tool at biba.org.uk connects applicants with brokers experienced in medical travel cover. The ABI's signposting requirement also means that any mainstream insurer that cannot offer suitable cover must direct applicants to these specialist resources.
How We Verified This Guide
This guide was researched against primary UK sources including the Consumer Insurance (Disclosure and Representations) Act 2012 via legislation.gov.uk, the FCA Consumer Duty policy statement PS22/9, the Financial Ombudsman Service's travel insurance guidance, the MoneyHelper travel insurance directory, the ABI's medical conditions signposting guidance, and the NHS Business Services Authority GHIC information pages. Last reviewed May 2026 by Chandraketu Tripathi, finance editor at Kaeltripton.
